Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetesMichael J. Haller, Desmond Schatz, Baiming Zou et al.|Journal of Clinical Investigation|2014Cited by 164
Central Role for Interleukin-2 in Type 1 DiabetesMaigan A. Hulme, Todd M. Brusko, Clive Wasserfall et al.|Diabetes|2011Cited by 136
Influence of Membrane CD25 Stability on T Lymphocyte Activity: Implications for ImmunoregulationTodd M. Brusko, Mark A. Atkinson, Desmond Schatz et al.|PLoS ONE|2009Cited by 79